Control of total afucosylated glycoforms of antibodies produced in cell culture
AU2023285706B2Pending Publication Date: 2026-07-23AMGEN INC
View PDF 3 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- AU · AU
- Patent Type
- Applications
- Current Assignee / Owner
- AMGEN INC
- Filing Date
- 2023-12-18
- Publication Date
- 2026-07-23
Smart Images

Figure 00000049_0000 
Figure 00000050_0000 
Figure 00000051_0000
Abstract
Provided herein are methods of modulating the levels of total afucosylated (TAF) glycoforms of a recombinant glycosylated protein produced by glycosylation-competent cells in a cell culture. In exemplary embodiments, the methods comprise maintaining the cell culture at an initial set point pH for an initial cell culture period. Related compositions comprising glycosylated proteins and TAF glycoforms thereof are also provided herein. 20 23 28 57 06 18 D ec 2 02 3 A B S T R A C T 2 0 2 3 2 8 5 7 0 6 1 8 D e c 2 0 2 3
Need to check novelty before this filing date? Find Prior Art